Latigo Biotherapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LTGO | LKFT | BHVN | LRMR | LBRX | LXRX | |
|---|---|---|---|---|---|---|
| Market cap | 1.06B | 1.94B | 1.78B | 262.82M | 1.16B | 734.18M |
| P/E (TTM) | — | 2.8 | — | — | 359.3 | — |
| Forward P/E | -7.7 | -24.9 | -6.3 | -2.4 | -7.0 | -8.7 |
| Price/book | -0.1 | 10.5 | 145.8 | 2.1 | 3.1 | 4.2 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −12.33% | −12.35% | −29.11% | −37.18% | +131.61% | +16.67% |
| Today | +0.13% | −0.54% | −2.24% | −5.24% | −3.47% | −1.79% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All LTGO news ›Larimar Prices $100M Stock Sale After Record Rally Fueled By FDA Breakthrough Tag For Protein Replacement Therapy
Shares of Larimar Therapeutics Inc. (LRMR) surged over 60% on Wednesday to their strongest session on record before pricing an upsized $100 million stock offering, extending gains following the FDA’s Breakthrough Therapy designation for…
Latigo Biotherapeutics (NASDAQ:LTGO) Hits New 12-Month Low – Here’s Why
Latigo Biotherapeutics, Inc. (NASDAQ:LTGO – Get Free Report) shares hit a new 52-week low on Thursday. The stock traded as low as $15.27 and last traded at $15.52, with a volume of 241512 shares trading hands. The stock had previously…
Latigo Biotherapeutics (NASDAQ:LTGO) Stock Price Up 5.1% - Here's What Happened
Latigo Biotherapeutics, Inc. (NASDAQ:LTGO - Get Free Report) shares rose 5.1% during mid-day trading on Thursday. The company traded as high as $17.55 and last traded at $17.55. Approximately 15,697 shares were traded during mid-day…
Latigo Biotherapeutics (NASDAQ:LTGO) Upgraded at Wall Street Zen
Posted by Michael Walen on Sep 29th, 2026 Wall Street Zen upgraded shares of Latigo Biotherapeutics (NASDAQ:LTGO – Free Report) from a sell rating to a hold rating in a report published on Saturday,Wall Street Zen reports. Read Our Latest…
Lakefront Biotherapeutics Shares Jump 7.36% as Former Galapagos NV Continues Its Ongoing Corporate Reinvention
Lakefront Biotherapeutics shares rose 7.36% on Euronext Amsterdam as investors continued to assess the former Galapagos NV's rebrand, strategic changes and financial outlook.
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketbeat.com3
-
defenseworld.net1
-
ibtimes.com.au1
-
stocktwits.com1
-
themarketsdaily.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.